iX Biopharma42C 
$0.020.00%24h
0.00%24h
Global rank29441
Market cap$13.00M
Change 7d0.00%
YTD Performance-48.89%
SP500 benchmarkUnderperform
P/E0
P/S2.98
Revenue$4.36M
Earnings-$7.09M
Dividend yield-
Main Sector
Healthcare
Category
iX Biopharma (42C) Cash on Hand
42C Cash on Hand in 2022: $4.81M
According to iX Biopharma latest financial reports the cash on hand of 42C is $4.81M, an decrease of -51.69% to 2022. At the end of 2022 company had $9.96M cash on hand. This amount reflects the liquid assets available to the company, which are crucial for its operational flexibility, investment opportunities, and overall financial security.
42C Cash on Hand History from 2019 to 2023
-
Value:-
42C Cash on Hand by year
| Year | Cash on Hand | Change |
|---|---|---|
| 2023 | $4.81M | -51.69% |
| 2022 | $9.96M | 117.47% |
| 2021 | $4.58M | 9.57% |
| 2020 | $4.18M | -64.32% |
| 2019 | $11.71M | - |
View the Top Cash on Hand Companies 
